|
Modulators | Known actions | Ref. |
|
Nucleic acids | | |
Btr | Under anaerobic conditions, Btr can increase the expression of BRG1 in E. coli by three times. | [102] |
LncRNA Evf2 | Evf2 directly inhibits BRG1 ATPase and chromatin remodeling activities. | [103] |
LncRNA UCA1 | UCA1, as a suppressor of BRG1, promotes bladder cancer cell proliferation by inhibiting BRG1. | [104] |
MiR-101, miR-199, and miR-155 | BRG1 expression is controlled by miR-101, miR-199, and miR-155 through binding to 3UTRs. | [105] |
MiR-155 | There is a negative correlation between miR-155 level and BRG1 in normal NK, as well as two NKTCL cell lines and the MOLT4 cell line. | [106, 107] |
MiR-139-5p | MiR-139-5p promotes apoptosis and suppresses proliferation of human airway smooth muscle cells by decreasing the BRG1. | [108, 109] |
MiR-144-3p | MiR-144-3p promotes OGD/R-induced neuronal injury by negatively regulating BRG1/Nrf2/ARE signaling. | [46] |
MiR-199a-5p | Downregulation of miR-199a-5p can protect neurons from OGD/R-induced neuron damage by upregulating BRG1 to activate Nrf2/HO-1 signaling. | [47] [110] |
MiR-21 | BRG1 is a direct target of miR-21. | [111] |
MiR-221/222 | BRG1 is the most likely target affected by miR-221/222 during LPS tolerance, and increased expression of miR-221/222 reduces BRG1 expression. | [112] |
MiR-206 | BRG1 may be an important gene target of miR-206 during carcinogenesis and osteogenesis. | [113] |
MiR-302 | MiR-302 binds the 3UTRs and directly regulates the BRG1 complex subunits BAF53a and BAF170. | [114] |
MiR-99a | BRG1 is positively regulated by miR-99a and is involved in hypoxia-induced cell injuries in H9C2 cells. | [19] |
NcRNA Xist | Xist binding inhibits BRG1’s nucleosome-remodeling activity and results in expulsion of the SWI/SNF complex from the Xi. | [115] |
Proteins | | |
Angiotensin II | Expression of BRG1 is increased in vitro when cardiomyocytes are stimulated with angiotensin II or a β-adrenergic agonist. | [116] |
Calcineurin | Calcineurin (Cn) regulates the ability of BRG1 and other SWI/SNF enzyme subunits to stably associate with myogenic promoters during differentiation. | [117] |
Camk2a | Camk2a-Cre-mediated conditional deletion of BRG1 leads to perinatal hydrocephalus. | [118] |
CK2 | CK2-mediated phosphorylation of BRG1 regulates myoblast proliferation. | [119] |
Cdx | Cdx transcription factors regulate target gene expression, in part, through recruitment of BRG1-associated SWI/SNF chromatin remodeling activity. | [120] |
Gcn5 | In vivo and in vitro, the Snf2 subunit of the SWI/SNF complex is acetylated directly by the Gcn5-containing complexes. | [121] |
NRG1 | BRG1 expression is inhibited in the NRG1Δ mutant and BRG1’s induction was blocked by overexpression of NRG1. | [122] |
p63 | P63 directly modulates the expression of BRG1. | [123] |
PPARγ | PPARγ activation-mediated inhibition of BRG1 activity through NF-κB pathway. | [124] |
SCF FBW7 | SCF FBW7-mediated degradation of BRG1 inhibits gastric cancer metastasis. | [125] |
SRG3 | SRG3 protects the major components of the SWI/SNF complex from proteasomal degradation by interacting directly with them. | [126] |
|